Clinical and Therapeutic Aspects of the Antiphospholipid Syndrome
- 1 February 1995
- journal article
- review article
- Published by SAGE Publications in Lupus
- Vol. 4 (1_suppl) , S23-S25
- https://doi.org/10.1177/096120339400400106
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosusArthritis & Rheumatism, 1994
- Seronegative Antiphospholipid Syndrome Associated with Plasminogen Activator InhibitorLupus, 1994
- Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.The Journal of Experimental Medicine, 1994
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsThe American Journal of Medicine, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- A “primary” thrombotic syndrome: Absence of anti-phospholipid antibodiesClinical Rheumatology, 1991
- Antiphospholipid antibodies and cerebral ischemia in young peopleNeurology, 1990
- Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.Annals of the Rheumatic Diseases, 1987
- Chorea in systemic lupus erythematosus and “lupus-like” disease: Association with antiphospholipid antibodiesSeminars in Arthritis and Rheumatism, 1987
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.BMJ, 1983